Jonathan D Bender

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances (2024)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)